Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 18 Issue 2, February 2022

Feeling the heat

Shown is a zebrafish embryo expressing a fluorescent fusion of the optogenetic protein BcLOV4, whose activity responds not only to light but also to temperature. BcLOV4 localizes to the plasma membrane in response to blue light, but its membrane association subsequently decays at a rate that depends on temperature.

See Benman et al.

Image credit: Lukasz Bugaj, University of Pennsylvania. Cover Design: Alex Wing

Research Highlights

Top of page ⤴

News & Views

  • Optogenetic and thermogenetic tools have been limited to applications for single-state control of cellular processes. A single-component optogenetic tool was found to act as both a temperature sensor and a photoreceptor, enabling multi-state control of developmental signaling.

    • Maxwell Z. Wilson
    News & Views
  • To avoid strife at the interface of basic carbon and nitrogen metabolism, Bacillus subtilis has developed a rather combative solution. If needed, its glutamate synthase suppresses conflicting glutamate breakdown by directly binding and immobilizing its metabolic opponent, glutamate dehydrogenase.

    • Marcus D. Hartmann
    News & Views
  • Reliable quantification and tracing of RNA molecules remain challenging goals. A new fluorescent RNA tag, developed based on a natural adenine-sensing riboswitch and named Squash, offers superior imaging properties and accurate quantification in living cells.

    • Abhishek Kaushik
    • Ashok Nuthanakanti
    • Alexander Serganov
    News & Views
  • Chimeric antigen receptor T cells (CAR-T cells) are often hindered by the concurrent challenges of variable antigen expression patterns and immunosuppressive tumor microenvironments. A new approach enhances CAR-T cells by coexpressing bacterial enzymes that activate prodrugs in high concentrations at the disease site.

    • Rosa Vincent
    • Tal Danino
    News & Views
Top of page ⤴

Review Articles

  • The Review summarized the recent progress in chemical probes and drug candidates for epigenetic writer enzymes and discussed the implication of targeting the chromatin regulatory landscape in cancer biology and therapy.

    • Andrew R. Conery
    • Jennifer L. Rocnik
    • Patrick Trojer
    Review Article
Top of page ⤴

Articles

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links